Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia

Psychopharmacology

Volumn 202, Issue 4, 2009, Pages 579-587

  Becker, Axel ^a   Grecksch, Gisela ^a   Zernig, Gerald ^b   Ladstaetter, Elisabeth ^b   Hiemke, Christoph ^c   Schmitt, Ulrich ^c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Haloperidol; Locomotor activity; Morphine; Pain; Risperidone; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; HALOPERIDOL; KETAMINE; MORPHINE; MU OPIATE RECEPTOR; RISPERIDONE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG METABOLISM; LOCOMOTION; MALE; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SYMPTOM;

ANALGESICS, OPIOID; ANIMALS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; KETAMINE; MALE; MORPHINE; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 59849099843     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1336-z     Document Type: Article

References (58)

1. American Psychiatric Association's Task Force on Research Ethics 2006 Ethical principles and practices for research involving human participants with mental illness Psychiatr Serv 57 552 557
2. A Becker G Grecksch 2000 Social memory is impaired in neonatally ibotenic acid lesioned rats Behav Brain Res 109 137 140
3. A Becker G Grecksch 2003 Haloperidol and clozapine affect social behaviour in rats postnatally lesioned in the ventral hippocampus Pharmacol Biochem Behav 76 1 8
4. A Becker G Grecksch 2004 Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity Prog Neuropsychopharmacol Biol Psychiatry 28 1267 1277
5. A Becker B Peters H Schroeder T Mann G Huether G Grecksch 2003 Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 27 687 700
6. A Becker G Grecksch H Schroeder 2006 Pain sensitivity is altered in animals after subchronic ketamine treatment Psychopharmacology (Berl) 189 237 247
7. HG Bernstein D Krell HM Emrich B Baumann P Danos S Diekmann B Bogerts 2002 Fewer beta-endorphin expressing arcuate nucleus neurons and reduced beta-endorphinergic innervation of paraventricular neurons in schizophrenics and patients with depression Cell Mol Biol (Noisy-le-grand) 48 Online Pub OL259 OL265
8. LK Bickerstaff SC Harris RS Leggett KC Cheah 1988 Pain insensitivity in schizophrenic patients. A surgical dilemma Arch Surg 123 49 51
9. R Blumensohn D Ringler I Eli 2002 Pain perception in patients with schizophrenia J Nerv Ment Dis 190 481 483
10. J Brockmöller J Kirchheiner J Schmider S Walter C Sachse B Müller-Oerlinghausen I Roots 2002 The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment Clin Pharmacol Ther 72 438 452
11. PF Buckley 2007 Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents J Clin Psychiatry 68 Suppl 6 5 9
12. WH Chan WZ Sun TH Ueng 2005 Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications J Toxicol Environ Health A 68 1581 1597
13. R Charlier M Prost F Binon G Deltourg 1961 Etude pharmacologique d'un antitussif le fumarate acid, de phenethyl-1(propyne-2yl)-4-propionoxy-4- piperidine Arch Int Pharmacodyn Ther 134 306 327
14. RR Conley DL Kelly 2002 Current status of antipsychotic treatment Curr Drug Targets CNS Neurol Disord 1 123 128
15. GC Davis MS Buchsbaum D Naber D Pickar R Post D van Kammen WE Bunney Jr 1982 Altered pain perception and cerebrospinal endorphins in psychiatric illness Ann N Y Acad Sci 398 366 373
16. RH Dworkin 1994 Pain insensitivity in schizophrenia: a neglected phenomenon and some implications Schizophr Bull 20 235 248
17. BA Ellenbroek 2007
18. DA Fishbain 1982 Pain insensitivity in psychosis Ann Emerg Med 11 630 632
19. DA Fishbain RB Cutler J Lewis B Cole RS Rosomoff HL Rosomoff 2004 Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review Pain Med 5 359 365
20. JA Flores F El Banoua B Galan-Rodriguez E Fernandez-Espejo 2004 Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors Pain 110 205 214
21. E Geuze HG Westenberg A Jochims CS de Kloet M Bohus E Vermetten C Schmahl 2007 Altered pain processing in veterans with posttraumatic stress disorder Arch Gen Psychiatry 64 76 85
22. T Jochum A Letzsch W Greiner G Wagner H Sauer KJ Bär 2006 Influence of antipsychotic medication on pain perception in schizophrenia Psychiatry Res 142 151 156
23. S Kapur P Seeman 2002 NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia Mol Psychiatry 7 837 844
24. MA King S Bradshaw AH Chang JE Pintar GW Pasternak 2001 Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system J Neurosci 21 7788 7792
25. KM Kirschbaum S Finger F Vogel R Burger M Gerlach P Riederer C Hiemke 2008 LC with column-switching and spectrophotometric detection for determination of risperidone and 9-hydroxyrisperidone in human serum Chromatographia 67 321 324
26. S Kudo T Ishizaki 1999 Pharmacokinetics of haloperidol: an update Clin Pharmacokinet 37 435 456
27. A Kudoh H Ishihara A Matsuki 2000 Current perception thresholds and postoperative pain in schizophrenic patients Reg Anesth Pain Med 25 475 479
28. H Kuribara 1995 Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice Eur J Pharmacol 275 251 258
29. J Leon MT Susce RM Pan PJ Wedlund ML Orrego FJ Diaz 2007 A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels Pharmacopsychiatry 40 93 102
30. A Livingston AE Waterman 1978 The development of tolerance to ketamine in rats and the significance of hepatic metabolism Br J Pharmacol 64 63 69
31. JM Loch J Potter KA Bachmann 1995 The influence of anesthetic agents on rat hepatic cytochromes P450 in vivo Pharmacology 50 146 153
32. P Ludascher M Bohus K Lieb A Philipsen A Jochims C Schmahl 2007 Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder Psychiatry Res 149 291 296
33. MP Marietta ME Vore WL Way AJ Trevor 1977 Characterization of ketamine induction of hepatic microsomal drug metabolism Biochem Pharmacol 26 2451 2453
34. HP Maurer C Sauer DS Theobald 2006 Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine Ther Drug Monit 28 447 453
35. A Michael-Titus R Bousselmame J Costentin 1990 Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link Eur J Pharmacol 187 201 207
36. MJ Morgan KB Franklin 1991 Dopamine receptor subtypes and formalin test analgesia Pharmacol Biochem Behav 40 317 322
37. JW Olney NB Farber 1995 Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 52 998 1007
38. L Pan FM Belpaire 1999 In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol Eur J Clin Pharmacol 55 599 604
39. E Richelson 1999 Receptor pharmacology of neuroleptics: relation to clinical effects J Clin Psychiatry 60 Suppl 10 5 14
40. H Russig A Kovacevic CA Murphy J Feldon 2003 Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion Psychopharmacology (Berl) 170 263 270
41. NA Schmajuk B Christiansen L Cox 2000 Haloperidol reinstates latent inhibition impaired by hippocampal lesions: data and theory Behav Neurosci 114 659 670
42. S Schreiber MM Backer R Weizman CG Pick 1997 Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice Neurosci Lett 228 25 28
43. P Seeman 2002 Atypical antipsychotics: mechanism of action Can J Psychiatry 47 27 38
44. P Seeman 2006 Targeting the dopamine D2 receptor in schizophrenia Expert Opin Ther Targets 10 515 531
45. A Serrano MA Aguilar C Manzanedo M Rodriguez-Arias J Minarro 2002 Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice Prog Neuropsychopharmacol Biol Psychiatry 26 1263 1271
46. E Shadach I Gaisler D Schiller I Weiner 2000 The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin Neuropsychopharmacology 23 151 161
47. JG Shin N Soukhova DA Flockhart 1999 Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6 Drug Metab Dispos 27 1078 1084
48. MK Singh LL Giles HA Nasrallah 2006 Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract 12 90 102
49. E Spina J de Leon 2007 Metabolic drug interactions with newer antipsychotics: a comparative review Basic Clin Pharmacol Toxicol 100 4 22
50. J van der Weide EH Baalen-Benedek JE Kootstra-Ros 2005 Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype Ther Drug Monit 27 478 483
51. EC Warburton MH Joseph J Feldon I Weiner JA Gray 1994 Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron Psychopharmacology (Berl) 114 657 664
52. VM Wiegant E Ronken G Kovacs D De Wied 1992 Endorphins and schizophrenia Prog Brain Res 93 433 453
53. JD Wines Jr RD Weiss 1999 Opioid withdrawal during risperidone treatment J Clin Psychopharmacol 19 265 267
54. MR Zarrindast A Zarghi 1992 Morphine stimulates locomotor activity by an indirect dopaminergic mechanism: possible D-1 and D-2 receptor involvement Gen Pharmacol 23 1221 1225
55. MR Zarrindast Z Dinkoub H Homayoun A Bakhtiarian S Khavandgar 2002 Dopamine receptor mechanism(s) and morphine tolerance in mice J Psychopharmacol 16 261 266
56. CS Zhang Z Tan L Lu SN Wu Y He NF Gu GY Feng L He 2004 Polymorphism of prodynorphin promoter is associated with schizophrenia in Chinese population Acta Pharmacol Sin 25 1022 1026
57. ZQ Zhao YJ Gao YG Sun CS Zhao RW Gereau ZF Chen 2007 Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward Proc Natl Acad Sci USA 104 14519 14524
58. L Zuckerman M Rehavi R Nachman I Weiner 2003 Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia Neuropsychopharmacology 28 1778 1789